Health News

fluemen-july19.jpg Women are said to experience a more severe outcome from influenza A virus infection and recover slower than men, even when the viral load is the same in both the genders. Acupuncture-Breastcancer-012218.jpg One of the major drawback of aromatase inhibitors, a class of drugs, commonly used in the management of estrogen receptor-positive (ER+) breast cancer is the debilitating joint pain. A large clinical trial, which involved a total of 226 patients from 11 cancer centers, has found that acupuncture can significantly reduce the troublesome joint pain caused by the aromatase inhibitors. Scientists-Discussion-010318.jpg Hysterectomy, which refers to the surgical removal of a woman's uterus, is the second most common gynecologic surgery performed in the United States, next only to Caesarean Sections. Read More

Alzheimer's Tau Protein Raises Risk Of Cancer Too: Study

One of the hallmarks of Alzheimer's disease is the presence of neurofibrillary tangles inside neurons - i.e., the cells that make up the brain and the nervous system. The neurofibrillary tangles are composed of mutated Tau protein. So Tau is an attractive target for developing a new Alzheimer's therapy.
Read More

Wrinkles And Hair Loss Reversed: It's Restoring Mitochondrial Function Genius!

Studies on reversing the signs of aging like wrinkles and hair loss are of considerable interest to researchers and public at large. But what if these telltale signs of aging can be reversed?
Read More

Frequent Use Of Digital Media Linked To ADHD Symptoms In Adolescents, Says Study

Frequent use of digital media is associated with the development of attention-deficit/hyperactivity disorder (ADHD) symptoms during adolescence, finds a new study conducted by a team of researchers of the University of Southern California.
Read More

Follow RTT
FDA Calendar
Event DateSymbolDrug NameEvent Name
12/19/18SAGEBrexanolone IV (NDA) FDA decision on Brexanolone IV for the treatment of postpartum depression
12/05/18RHHBYTECENTRIQ (sBLA)FDA decision on TECENTRIQ in combination with Avastin or bevacizumab, paclitaxel and carboplatin or chemotherapy for initial treatment of people with metastatic NSCLC
11/18/18AQSTAQST-119 (NDA)FDA decision on AQST-119 for erectile dysfunction
11/13/18TBPHYUPELRI (NDA) FDA decision on YUPELRI for moderate to very severe COPD
11/13/18MYLYUPELRI (NDA)FDA decision on YUPELRI for moderate to very severe COPD
11/09/18MRKKEYTRUDA (sBLA)FDA decision on KEYTRUDA as a treatment for previously treated patients with advanced hepatocellular carcinoma
View All

FDA Device Approval
No Records Found
View All